nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—SLC6A4—Alzheimer's disease	0.213	0.587	CbGaD
Escitalopram—CYP2D6—Alzheimer's disease	0.15	0.413	CbGaD
Escitalopram—CYP2D6—Rivastigmine—Alzheimer's disease	0.0606	0.213	CbGbCtD
Escitalopram—CYP2C19—Memantine—Alzheimer's disease	0.0553	0.194	CbGbCtD
Escitalopram—CYP2D6—Donepezil—Alzheimer's disease	0.0485	0.17	CbGbCtD
Escitalopram—CYP3A4—Rivastigmine—Alzheimer's disease	0.0385	0.135	CbGbCtD
Escitalopram—CYP2D6—Galantamine—Alzheimer's disease	0.0312	0.11	CbGbCtD
Escitalopram—CYP3A4—Donepezil—Alzheimer's disease	0.0308	0.108	CbGbCtD
Escitalopram—CYP3A4—Galantamine—Alzheimer's disease	0.0199	0.0697	CbGbCtD
Escitalopram—HTR2C—choroid plexus—Alzheimer's disease	0.0126	0.253	CbGeAlD
Escitalopram—SLC6A2—locus ceruleus—Alzheimer's disease	0.00649	0.13	CbGeAlD
Escitalopram—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00381	0.0767	CbGeAlD
Escitalopram—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00369	0.0741	CbGeAlD
Escitalopram—Citalopram—SLC6A4—Alzheimer's disease	0.00167	0.587	CrCbGaD
Escitalopram—Citalopram—CYP2D6—Alzheimer's disease	0.00117	0.413	CrCbGaD
Escitalopram—SLC6A3—forebrain—Alzheimer's disease	0.000996	0.02	CbGeAlD
Escitalopram—HTR2C—forebrain—Alzheimer's disease	0.000963	0.0193	CbGeAlD
Escitalopram—SLC6A3—telencephalon—Alzheimer's disease	0.000916	0.0184	CbGeAlD
Escitalopram—SLC6A4—forebrain—Alzheimer's disease	0.000913	0.0183	CbGeAlD
Escitalopram—CHRM1—forebrain—Alzheimer's disease	0.000909	0.0183	CbGeAlD
Escitalopram—HTR2C—telencephalon—Alzheimer's disease	0.000885	0.0178	CbGeAlD
Escitalopram—SLC6A4—telencephalon—Alzheimer's disease	0.000839	0.0169	CbGeAlD
Escitalopram—CHRM1—telencephalon—Alzheimer's disease	0.000836	0.0168	CbGeAlD
Escitalopram—SLC6A2—forebrain—Alzheimer's disease	0.000803	0.0161	CbGeAlD
Escitalopram—ADRA1A—forebrain—Alzheimer's disease	0.000747	0.015	CbGeAlD
Escitalopram—SLC6A2—telencephalon—Alzheimer's disease	0.000739	0.0148	CbGeAlD
Escitalopram—ADRA1A—telencephalon—Alzheimer's disease	0.000687	0.0138	CbGeAlD
Escitalopram—HRH1—forebrain—Alzheimer's disease	0.000578	0.0116	CbGeAlD
Escitalopram—SLC6A3—nervous system—Alzheimer's disease	0.000541	0.0109	CbGeAlD
Escitalopram—HRH1—telencephalon—Alzheimer's disease	0.000532	0.0107	CbGeAlD
Escitalopram—HTR2C—nervous system—Alzheimer's disease	0.000523	0.0105	CbGeAlD
Escitalopram—SLC6A3—central nervous system—Alzheimer's disease	0.000521	0.0105	CbGeAlD
Escitalopram—SLC6A3—cerebellum—Alzheimer's disease	0.000509	0.0102	CbGeAlD
Escitalopram—HTR2C—central nervous system—Alzheimer's disease	0.000503	0.0101	CbGeAlD
Escitalopram—SLC6A4—nervous system—Alzheimer's disease	0.000495	0.00996	CbGeAlD
Escitalopram—CHRM1—nervous system—Alzheimer's disease	0.000494	0.00992	CbGeAlD
Escitalopram—SLC6A4—central nervous system—Alzheimer's disease	0.000477	0.00959	CbGeAlD
Escitalopram—CHRM1—central nervous system—Alzheimer's disease	0.000475	0.00955	CbGeAlD
Escitalopram—CYP2D6—forebrain—Alzheimer's disease	0.00044	0.00884	CbGeAlD
Escitalopram—SLC6A2—nervous system—Alzheimer's disease	0.000436	0.00877	CbGeAlD
Escitalopram—SLC6A2—central nervous system—Alzheimer's disease	0.00042	0.00844	CbGeAlD
Escitalopram—SLC6A3—brain—Alzheimer's disease	0.000413	0.00831	CbGeAlD
Escitalopram—ADRA1A—nervous system—Alzheimer's disease	0.000406	0.00815	CbGeAlD
Escitalopram—CYP2D6—telencephalon—Alzheimer's disease	0.000405	0.00813	CbGeAlD
Escitalopram—HTR2C—brain—Alzheimer's disease	0.000399	0.00803	CbGeAlD
Escitalopram—ADRA1A—central nervous system—Alzheimer's disease	0.00039	0.00785	CbGeAlD
Escitalopram—ADRA1A—cerebellum—Alzheimer's disease	0.000382	0.00767	CbGeAlD
Escitalopram—SLC6A4—brain—Alzheimer's disease	0.000379	0.00761	CbGeAlD
Escitalopram—CHRM1—brain—Alzheimer's disease	0.000377	0.00758	CbGeAlD
Escitalopram—SLC6A2—brain—Alzheimer's disease	0.000333	0.0067	CbGeAlD
Escitalopram—HRH1—nervous system—Alzheimer's disease	0.000314	0.00631	CbGeAlD
Escitalopram—ADRA1A—brain—Alzheimer's disease	0.00031	0.00623	CbGeAlD
Escitalopram—HRH1—central nervous system—Alzheimer's disease	0.000302	0.00607	CbGeAlD
Escitalopram—CYP3A4—nervous system—Alzheimer's disease	0.000243	0.00488	CbGeAlD
Escitalopram—HRH1—brain—Alzheimer's disease	0.00024	0.00482	CbGeAlD
Escitalopram—CYP2D6—nervous system—Alzheimer's disease	0.000239	0.0048	CbGeAlD
Escitalopram—CYP3A4—central nervous system—Alzheimer's disease	0.000234	0.0047	CbGeAlD
Escitalopram—CYP2D6—central nervous system—Alzheimer's disease	0.00023	0.00462	CbGeAlD
Escitalopram—CYP2D6—cerebellum—Alzheimer's disease	0.000225	0.00452	CbGeAlD
Escitalopram—CYP2D6—brain—Alzheimer's disease	0.000183	0.00367	CbGeAlD
Escitalopram—Haemorrhage—Rivastigmine—Alzheimer's disease	8.36e-05	0.000331	CcSEcCtD
Escitalopram—Hepatitis—Rivastigmine—Alzheimer's disease	8.36e-05	0.000331	CcSEcCtD
Escitalopram—Hyperhidrosis—Galantamine—Alzheimer's disease	8.35e-05	0.000331	CcSEcCtD
Escitalopram—Hallucination—Rivastigmine—Alzheimer's disease	8.32e-05	0.00033	CcSEcCtD
Escitalopram—Hypoaesthesia—Rivastigmine—Alzheimer's disease	8.32e-05	0.00033	CcSEcCtD
Escitalopram—Alopecia—Donepezil—Alzheimer's disease	8.32e-05	0.00033	CcSEcCtD
Escitalopram—Pharyngitis—Rivastigmine—Alzheimer's disease	8.3e-05	0.000329	CcSEcCtD
Escitalopram—Urinary tract disorder—Rivastigmine—Alzheimer's disease	8.26e-05	0.000327	CcSEcCtD
Escitalopram—Mental disorder—Donepezil—Alzheimer's disease	8.25e-05	0.000327	CcSEcCtD
Escitalopram—Oedema peripheral—Rivastigmine—Alzheimer's disease	8.24e-05	0.000326	CcSEcCtD
Escitalopram—Visual impairment—Memantine—Alzheimer's disease	8.24e-05	0.000326	CcSEcCtD
Escitalopram—Anorexia—Galantamine—Alzheimer's disease	8.23e-05	0.000326	CcSEcCtD
Escitalopram—Connective tissue disorder—Rivastigmine—Alzheimer's disease	8.22e-05	0.000326	CcSEcCtD
Escitalopram—Urethral disorder—Rivastigmine—Alzheimer's disease	8.2e-05	0.000325	CcSEcCtD
Escitalopram—Erythema—Donepezil—Alzheimer's disease	8.2e-05	0.000325	CcSEcCtD
Escitalopram—Malnutrition—Donepezil—Alzheimer's disease	8.2e-05	0.000325	CcSEcCtD
Escitalopram—Erythema multiforme—Memantine—Alzheimer's disease	8.08e-05	0.00032	CcSEcCtD
Escitalopram—Flatulence—Donepezil—Alzheimer's disease	8.08e-05	0.00032	CcSEcCtD
Escitalopram—Hypotension—Galantamine—Alzheimer's disease	8.07e-05	0.000319	CcSEcCtD
Escitalopram—Visual impairment—Rivastigmine—Alzheimer's disease	8.06e-05	0.000319	CcSEcCtD
Escitalopram—Tension—Donepezil—Alzheimer's disease	8.04e-05	0.000319	CcSEcCtD
Escitalopram—Dysgeusia—Donepezil—Alzheimer's disease	8.03e-05	0.000318	CcSEcCtD
Escitalopram—Eye disorder—Memantine—Alzheimer's disease	7.99e-05	0.000316	CcSEcCtD
Escitalopram—Tinnitus—Memantine—Alzheimer's disease	7.97e-05	0.000316	CcSEcCtD
Escitalopram—Nervousness—Donepezil—Alzheimer's disease	7.96e-05	0.000315	CcSEcCtD
Escitalopram—Cardiac disorder—Memantine—Alzheimer's disease	7.93e-05	0.000314	CcSEcCtD
Escitalopram—Flushing—Memantine—Alzheimer's disease	7.93e-05	0.000314	CcSEcCtD
Escitalopram—Back pain—Donepezil—Alzheimer's disease	7.93e-05	0.000314	CcSEcCtD
Escitalopram—Erythema multiforme—Rivastigmine—Alzheimer's disease	7.91e-05	0.000313	CcSEcCtD
Escitalopram—Muscle spasms—Donepezil—Alzheimer's disease	7.88e-05	0.000312	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	7.86e-05	0.000311	CcSEcCtD
Escitalopram—Eye disorder—Rivastigmine—Alzheimer's disease	7.82e-05	0.00031	CcSEcCtD
Escitalopram—Insomnia—Galantamine—Alzheimer's disease	7.81e-05	0.000309	CcSEcCtD
Escitalopram—Tinnitus—Rivastigmine—Alzheimer's disease	7.8e-05	0.000309	CcSEcCtD
Escitalopram—Cardiac disorder—Rivastigmine—Alzheimer's disease	7.76e-05	0.000307	CcSEcCtD
Escitalopram—Flushing—Rivastigmine—Alzheimer's disease	7.76e-05	0.000307	CcSEcCtD
Escitalopram—Angiopathy—Memantine—Alzheimer's disease	7.76e-05	0.000307	CcSEcCtD
Escitalopram—Paraesthesia—Galantamine—Alzheimer's disease	7.75e-05	0.000307	CcSEcCtD
Escitalopram—Vision blurred—Donepezil—Alzheimer's disease	7.73e-05	0.000306	CcSEcCtD
Escitalopram—Immune system disorder—Memantine—Alzheimer's disease	7.72e-05	0.000306	CcSEcCtD
Escitalopram—Mediastinal disorder—Memantine—Alzheimer's disease	7.71e-05	0.000305	CcSEcCtD
Escitalopram—Tremor—Donepezil—Alzheimer's disease	7.68e-05	0.000304	CcSEcCtD
Escitalopram—Somnolence—Galantamine—Alzheimer's disease	7.67e-05	0.000304	CcSEcCtD
Escitalopram—Chills—Memantine—Alzheimer's disease	7.67e-05	0.000304	CcSEcCtD
Escitalopram—Arrhythmia—Memantine—Alzheimer's disease	7.64e-05	0.000303	CcSEcCtD
Escitalopram—Ill-defined disorder—Donepezil—Alzheimer's disease	7.61e-05	0.000301	CcSEcCtD
Escitalopram—Dyspepsia—Galantamine—Alzheimer's disease	7.6e-05	0.000301	CcSEcCtD
Escitalopram—Angiopathy—Rivastigmine—Alzheimer's disease	7.59e-05	0.000301	CcSEcCtD
Escitalopram—Anaemia—Donepezil—Alzheimer's disease	7.58e-05	0.0003	CcSEcCtD
Escitalopram—Alopecia—Memantine—Alzheimer's disease	7.56e-05	0.000299	CcSEcCtD
Escitalopram—Mediastinal disorder—Rivastigmine—Alzheimer's disease	7.54e-05	0.000299	CcSEcCtD
Escitalopram—Agitation—Donepezil—Alzheimer's disease	7.53e-05	0.000298	CcSEcCtD
Escitalopram—Chills—Rivastigmine—Alzheimer's disease	7.5e-05	0.000297	CcSEcCtD
Escitalopram—Decreased appetite—Galantamine—Alzheimer's disease	7.5e-05	0.000297	CcSEcCtD
Escitalopram—Mental disorder—Memantine—Alzheimer's disease	7.49e-05	0.000297	CcSEcCtD
Escitalopram—Arrhythmia—Rivastigmine—Alzheimer's disease	7.47e-05	0.000296	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Galantamine—Alzheimer's disease	7.45e-05	0.000295	CcSEcCtD
Escitalopram—Malnutrition—Memantine—Alzheimer's disease	7.44e-05	0.000295	CcSEcCtD
Escitalopram—Fatigue—Galantamine—Alzheimer's disease	7.44e-05	0.000295	CcSEcCtD
Escitalopram—Malaise—Donepezil—Alzheimer's disease	7.39e-05	0.000293	CcSEcCtD
Escitalopram—Alopecia—Rivastigmine—Alzheimer's disease	7.39e-05	0.000293	CcSEcCtD
Escitalopram—Constipation—Galantamine—Alzheimer's disease	7.38e-05	0.000292	CcSEcCtD
Escitalopram—Vertigo—Donepezil—Alzheimer's disease	7.36e-05	0.000292	CcSEcCtD
Escitalopram—Syncope—Donepezil—Alzheimer's disease	7.35e-05	0.000291	CcSEcCtD
Escitalopram—Flatulence—Memantine—Alzheimer's disease	7.33e-05	0.00029	CcSEcCtD
Escitalopram—Mental disorder—Rivastigmine—Alzheimer's disease	7.33e-05	0.00029	CcSEcCtD
Escitalopram—Tension—Memantine—Alzheimer's disease	7.3e-05	0.000289	CcSEcCtD
Escitalopram—Dysgeusia—Memantine—Alzheimer's disease	7.29e-05	0.000289	CcSEcCtD
Escitalopram—Malnutrition—Rivastigmine—Alzheimer's disease	7.28e-05	0.000288	CcSEcCtD
Escitalopram—Erythema—Rivastigmine—Alzheimer's disease	7.28e-05	0.000288	CcSEcCtD
Escitalopram—Nervousness—Memantine—Alzheimer's disease	7.23e-05	0.000286	CcSEcCtD
Escitalopram—Loss of consciousness—Donepezil—Alzheimer's disease	7.2e-05	0.000285	CcSEcCtD
Escitalopram—Back pain—Memantine—Alzheimer's disease	7.2e-05	0.000285	CcSEcCtD
Escitalopram—Flatulence—Rivastigmine—Alzheimer's disease	7.17e-05	0.000284	CcSEcCtD
Escitalopram—Cough—Donepezil—Alzheimer's disease	7.15e-05	0.000283	CcSEcCtD
Escitalopram—Tension—Rivastigmine—Alzheimer's disease	7.14e-05	0.000283	CcSEcCtD
Escitalopram—Dysgeusia—Rivastigmine—Alzheimer's disease	7.13e-05	0.000282	CcSEcCtD
Escitalopram—Feeling abnormal—Galantamine—Alzheimer's disease	7.11e-05	0.000282	CcSEcCtD
Escitalopram—Convulsion—Donepezil—Alzheimer's disease	7.1e-05	0.000281	CcSEcCtD
Escitalopram—Hypertension—Donepezil—Alzheimer's disease	7.08e-05	0.00028	CcSEcCtD
Escitalopram—Nervousness—Rivastigmine—Alzheimer's disease	7.07e-05	0.00028	CcSEcCtD
Escitalopram—Gastrointestinal pain—Galantamine—Alzheimer's disease	7.06e-05	0.00028	CcSEcCtD
Escitalopram—Back pain—Rivastigmine—Alzheimer's disease	7.04e-05	0.000279	CcSEcCtD
Escitalopram—Vision blurred—Memantine—Alzheimer's disease	7.01e-05	0.000278	CcSEcCtD
Escitalopram—Muscle spasms—Rivastigmine—Alzheimer's disease	7e-05	0.000277	CcSEcCtD
Escitalopram—Chest pain—Donepezil—Alzheimer's disease	6.98e-05	0.000276	CcSEcCtD
Escitalopram—Arthralgia—Donepezil—Alzheimer's disease	6.98e-05	0.000276	CcSEcCtD
Escitalopram—Myalgia—Donepezil—Alzheimer's disease	6.98e-05	0.000276	CcSEcCtD
Escitalopram—Tremor—Memantine—Alzheimer's disease	6.97e-05	0.000276	CcSEcCtD
Escitalopram—Anxiety—Donepezil—Alzheimer's disease	6.95e-05	0.000275	CcSEcCtD
Escitalopram—Ill-defined disorder—Memantine—Alzheimer's disease	6.91e-05	0.000274	CcSEcCtD
Escitalopram—Discomfort—Donepezil—Alzheimer's disease	6.9e-05	0.000273	CcSEcCtD
Escitalopram—Anaemia—Memantine—Alzheimer's disease	6.88e-05	0.000272	CcSEcCtD
Escitalopram—Vision blurred—Rivastigmine—Alzheimer's disease	6.86e-05	0.000272	CcSEcCtD
Escitalopram—Agitation—Memantine—Alzheimer's disease	6.84e-05	0.000271	CcSEcCtD
Escitalopram—Dry mouth—Donepezil—Alzheimer's disease	6.83e-05	0.00027	CcSEcCtD
Escitalopram—Body temperature increased—Galantamine—Alzheimer's disease	6.82e-05	0.00027	CcSEcCtD
Escitalopram—Abdominal pain—Galantamine—Alzheimer's disease	6.82e-05	0.00027	CcSEcCtD
Escitalopram—Tremor—Rivastigmine—Alzheimer's disease	6.82e-05	0.00027	CcSEcCtD
Escitalopram—Ill-defined disorder—Rivastigmine—Alzheimer's disease	6.76e-05	0.000268	CcSEcCtD
Escitalopram—Confusional state—Donepezil—Alzheimer's disease	6.75e-05	0.000267	CcSEcCtD
Escitalopram—Anaemia—Rivastigmine—Alzheimer's disease	6.73e-05	0.000267	CcSEcCtD
Escitalopram—Malaise—Memantine—Alzheimer's disease	6.71e-05	0.000266	CcSEcCtD
Escitalopram—Agitation—Rivastigmine—Alzheimer's disease	6.69e-05	0.000265	CcSEcCtD
Escitalopram—Oedema—Donepezil—Alzheimer's disease	6.69e-05	0.000265	CcSEcCtD
Escitalopram—Vertigo—Memantine—Alzheimer's disease	6.69e-05	0.000265	CcSEcCtD
Escitalopram—Syncope—Memantine—Alzheimer's disease	6.67e-05	0.000264	CcSEcCtD
Escitalopram—Leukopenia—Memantine—Alzheimer's disease	6.66e-05	0.000264	CcSEcCtD
Escitalopram—Infection—Donepezil—Alzheimer's disease	6.65e-05	0.000263	CcSEcCtD
Escitalopram—Shock—Donepezil—Alzheimer's disease	6.58e-05	0.000261	CcSEcCtD
Escitalopram—Palpitations—Memantine—Alzheimer's disease	6.58e-05	0.00026	CcSEcCtD
Escitalopram—Malaise—Rivastigmine—Alzheimer's disease	6.57e-05	0.00026	CcSEcCtD
Escitalopram—Nervous system disorder—Donepezil—Alzheimer's disease	6.56e-05	0.00026	CcSEcCtD
Escitalopram—Thrombocytopenia—Donepezil—Alzheimer's disease	6.55e-05	0.000259	CcSEcCtD
Escitalopram—Vertigo—Rivastigmine—Alzheimer's disease	6.54e-05	0.000259	CcSEcCtD
Escitalopram—Loss of consciousness—Memantine—Alzheimer's disease	6.54e-05	0.000259	CcSEcCtD
Escitalopram—Syncope—Rivastigmine—Alzheimer's disease	6.53e-05	0.000259	CcSEcCtD
Escitalopram—Cough—Memantine—Alzheimer's disease	6.49e-05	0.000257	CcSEcCtD
Escitalopram—Hyperhidrosis—Donepezil—Alzheimer's disease	6.47e-05	0.000256	CcSEcCtD
Escitalopram—Convulsion—Memantine—Alzheimer's disease	6.45e-05	0.000255	CcSEcCtD
Escitalopram—Palpitations—Rivastigmine—Alzheimer's disease	6.43e-05	0.000255	CcSEcCtD
Escitalopram—Hypertension—Memantine—Alzheimer's disease	6.43e-05	0.000254	CcSEcCtD
Escitalopram—Loss of consciousness—Rivastigmine—Alzheimer's disease	6.4e-05	0.000253	CcSEcCtD
Escitalopram—Anorexia—Donepezil—Alzheimer's disease	6.38e-05	0.000253	CcSEcCtD
Escitalopram—Hypersensitivity—Galantamine—Alzheimer's disease	6.36e-05	0.000252	CcSEcCtD
Escitalopram—Cough—Rivastigmine—Alzheimer's disease	6.35e-05	0.000252	CcSEcCtD
Escitalopram—Myalgia—Memantine—Alzheimer's disease	6.34e-05	0.000251	CcSEcCtD
Escitalopram—Arthralgia—Memantine—Alzheimer's disease	6.34e-05	0.000251	CcSEcCtD
Escitalopram—Chest pain—Memantine—Alzheimer's disease	6.34e-05	0.000251	CcSEcCtD
Escitalopram—Anxiety—Memantine—Alzheimer's disease	6.31e-05	0.00025	CcSEcCtD
Escitalopram—Convulsion—Rivastigmine—Alzheimer's disease	6.31e-05	0.00025	CcSEcCtD
Escitalopram—Hypertension—Rivastigmine—Alzheimer's disease	6.29e-05	0.000249	CcSEcCtD
Escitalopram—Discomfort—Memantine—Alzheimer's disease	6.26e-05	0.000248	CcSEcCtD
Escitalopram—Hypotension—Donepezil—Alzheimer's disease	6.25e-05	0.000248	CcSEcCtD
Escitalopram—Arthralgia—Rivastigmine—Alzheimer's disease	6.2e-05	0.000246	CcSEcCtD
Escitalopram—Chest pain—Rivastigmine—Alzheimer's disease	6.2e-05	0.000246	CcSEcCtD
Escitalopram—Myalgia—Rivastigmine—Alzheimer's disease	6.2e-05	0.000246	CcSEcCtD
Escitalopram—Dry mouth—Memantine—Alzheimer's disease	6.2e-05	0.000245	CcSEcCtD
Escitalopram—Asthenia—Galantamine—Alzheimer's disease	6.19e-05	0.000245	CcSEcCtD
Escitalopram—Anxiety—Rivastigmine—Alzheimer's disease	6.18e-05	0.000245	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	6.16e-05	0.000244	CcSEcCtD
Escitalopram—Confusional state—Memantine—Alzheimer's disease	6.12e-05	0.000243	CcSEcCtD
Escitalopram—Discomfort—Rivastigmine—Alzheimer's disease	6.12e-05	0.000243	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	6.1e-05	0.000241	CcSEcCtD
Escitalopram—Oedema—Memantine—Alzheimer's disease	6.07e-05	0.000241	CcSEcCtD
Escitalopram—Dry mouth—Rivastigmine—Alzheimer's disease	6.06e-05	0.00024	CcSEcCtD
Escitalopram—Insomnia—Donepezil—Alzheimer's disease	6.05e-05	0.00024	CcSEcCtD
Escitalopram—Infection—Memantine—Alzheimer's disease	6.03e-05	0.000239	CcSEcCtD
Escitalopram—Paraesthesia—Donepezil—Alzheimer's disease	6.01e-05	0.000238	CcSEcCtD
Escitalopram—Confusional state—Rivastigmine—Alzheimer's disease	5.99e-05	0.000237	CcSEcCtD
Escitalopram—Shock—Memantine—Alzheimer's disease	5.98e-05	0.000237	CcSEcCtD
Escitalopram—Dyspnoea—Donepezil—Alzheimer's disease	5.96e-05	0.000236	CcSEcCtD
Escitalopram—Nervous system disorder—Memantine—Alzheimer's disease	5.96e-05	0.000236	CcSEcCtD
Escitalopram—Somnolence—Donepezil—Alzheimer's disease	5.95e-05	0.000236	CcSEcCtD
Escitalopram—Thrombocytopenia—Memantine—Alzheimer's disease	5.95e-05	0.000236	CcSEcCtD
Escitalopram—Oedema—Rivastigmine—Alzheimer's disease	5.94e-05	0.000235	CcSEcCtD
Escitalopram—Tachycardia—Memantine—Alzheimer's disease	5.93e-05	0.000235	CcSEcCtD
Escitalopram—Diarrhoea—Galantamine—Alzheimer's disease	5.91e-05	0.000234	CcSEcCtD
Escitalopram—Infection—Rivastigmine—Alzheimer's disease	5.9e-05	0.000234	CcSEcCtD
Escitalopram—Skin disorder—Memantine—Alzheimer's disease	5.9e-05	0.000234	CcSEcCtD
Escitalopram—Dyspepsia—Donepezil—Alzheimer's disease	5.89e-05	0.000233	CcSEcCtD
Escitalopram—Hyperhidrosis—Memantine—Alzheimer's disease	5.87e-05	0.000233	CcSEcCtD
Escitalopram—Shock—Rivastigmine—Alzheimer's disease	5.85e-05	0.000232	CcSEcCtD
Escitalopram—Nervous system disorder—Rivastigmine—Alzheimer's disease	5.83e-05	0.000231	CcSEcCtD
Escitalopram—Thrombocytopenia—Rivastigmine—Alzheimer's disease	5.82e-05	0.00023	CcSEcCtD
Escitalopram—Decreased appetite—Donepezil—Alzheimer's disease	5.82e-05	0.00023	CcSEcCtD
Escitalopram—Tachycardia—Rivastigmine—Alzheimer's disease	5.8e-05	0.00023	CcSEcCtD
Escitalopram—Anorexia—Memantine—Alzheimer's disease	5.79e-05	0.000229	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Donepezil—Alzheimer's disease	5.78e-05	0.000229	CcSEcCtD
Escitalopram—Skin disorder—Rivastigmine—Alzheimer's disease	5.77e-05	0.000229	CcSEcCtD
Escitalopram—Fatigue—Donepezil—Alzheimer's disease	5.77e-05	0.000228	CcSEcCtD
Escitalopram—Hyperhidrosis—Rivastigmine—Alzheimer's disease	5.74e-05	0.000228	CcSEcCtD
Escitalopram—Constipation—Donepezil—Alzheimer's disease	5.72e-05	0.000227	CcSEcCtD
Escitalopram—Pain—Donepezil—Alzheimer's disease	5.72e-05	0.000227	CcSEcCtD
Escitalopram—Dizziness—Galantamine—Alzheimer's disease	5.71e-05	0.000226	CcSEcCtD
Escitalopram—Hypotension—Memantine—Alzheimer's disease	5.68e-05	0.000225	CcSEcCtD
Escitalopram—Anorexia—Rivastigmine—Alzheimer's disease	5.66e-05	0.000224	CcSEcCtD
Escitalopram—Hypotension—Rivastigmine—Alzheimer's disease	5.55e-05	0.00022	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Memantine—Alzheimer's disease	5.53e-05	0.000219	CcSEcCtD
Escitalopram—Feeling abnormal—Donepezil—Alzheimer's disease	5.51e-05	0.000218	CcSEcCtD
Escitalopram—Insomnia—Memantine—Alzheimer's disease	5.49e-05	0.000218	CcSEcCtD
Escitalopram—Vomiting—Galantamine—Alzheimer's disease	5.49e-05	0.000217	CcSEcCtD
Escitalopram—Gastrointestinal pain—Donepezil—Alzheimer's disease	5.47e-05	0.000217	CcSEcCtD
Escitalopram—Paraesthesia—Memantine—Alzheimer's disease	5.45e-05	0.000216	CcSEcCtD
Escitalopram—Rash—Galantamine—Alzheimer's disease	5.44e-05	0.000216	CcSEcCtD
Escitalopram—Dermatitis—Galantamine—Alzheimer's disease	5.44e-05	0.000215	CcSEcCtD
Escitalopram—Dyspnoea—Memantine—Alzheimer's disease	5.42e-05	0.000214	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	5.41e-05	0.000214	CcSEcCtD
Escitalopram—Headache—Galantamine—Alzheimer's disease	5.41e-05	0.000214	CcSEcCtD
Escitalopram—Somnolence—Memantine—Alzheimer's disease	5.4e-05	0.000214	CcSEcCtD
Escitalopram—Insomnia—Rivastigmine—Alzheimer's disease	5.37e-05	0.000213	CcSEcCtD
Escitalopram—Dyspepsia—Memantine—Alzheimer's disease	5.35e-05	0.000212	CcSEcCtD
Escitalopram—Paraesthesia—Rivastigmine—Alzheimer's disease	5.34e-05	0.000211	CcSEcCtD
Escitalopram—Urticaria—Donepezil—Alzheimer's disease	5.31e-05	0.00021	CcSEcCtD
Escitalopram—Dyspnoea—Rivastigmine—Alzheimer's disease	5.3e-05	0.00021	CcSEcCtD
Escitalopram—Abdominal pain—Donepezil—Alzheimer's disease	5.29e-05	0.000209	CcSEcCtD
Escitalopram—Body temperature increased—Donepezil—Alzheimer's disease	5.29e-05	0.000209	CcSEcCtD
Escitalopram—Somnolence—Rivastigmine—Alzheimer's disease	5.28e-05	0.000209	CcSEcCtD
Escitalopram—Decreased appetite—Memantine—Alzheimer's disease	5.28e-05	0.000209	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Memantine—Alzheimer's disease	5.24e-05	0.000208	CcSEcCtD
Escitalopram—Fatigue—Memantine—Alzheimer's disease	5.24e-05	0.000207	CcSEcCtD
Escitalopram—Dyspepsia—Rivastigmine—Alzheimer's disease	5.23e-05	0.000207	CcSEcCtD
Escitalopram—Pain—Memantine—Alzheimer's disease	5.19e-05	0.000206	CcSEcCtD
Escitalopram—Constipation—Memantine—Alzheimer's disease	5.19e-05	0.000206	CcSEcCtD
Escitalopram—Decreased appetite—Rivastigmine—Alzheimer's disease	5.17e-05	0.000205	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	5.13e-05	0.000203	CcSEcCtD
Escitalopram—Nausea—Galantamine—Alzheimer's disease	5.13e-05	0.000203	CcSEcCtD
Escitalopram—Fatigue—Rivastigmine—Alzheimer's disease	5.12e-05	0.000203	CcSEcCtD
Escitalopram—Constipation—Rivastigmine—Alzheimer's disease	5.08e-05	0.000201	CcSEcCtD
Escitalopram—Pain—Rivastigmine—Alzheimer's disease	5.08e-05	0.000201	CcSEcCtD
Escitalopram—Feeling abnormal—Memantine—Alzheimer's disease	5.01e-05	0.000198	CcSEcCtD
Escitalopram—Gastrointestinal pain—Memantine—Alzheimer's disease	4.97e-05	0.000197	CcSEcCtD
Escitalopram—Hypersensitivity—Donepezil—Alzheimer's disease	4.93e-05	0.000195	CcSEcCtD
Escitalopram—Feeling abnormal—Rivastigmine—Alzheimer's disease	4.9e-05	0.000194	CcSEcCtD
Escitalopram—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	4.86e-05	0.000192	CcSEcCtD
Escitalopram—Urticaria—Memantine—Alzheimer's disease	4.83e-05	0.000191	CcSEcCtD
Escitalopram—Body temperature increased—Memantine—Alzheimer's disease	4.8e-05	0.00019	CcSEcCtD
Escitalopram—Abdominal pain—Memantine—Alzheimer's disease	4.8e-05	0.00019	CcSEcCtD
Escitalopram—Asthenia—Donepezil—Alzheimer's disease	4.8e-05	0.00019	CcSEcCtD
Escitalopram—Pruritus—Donepezil—Alzheimer's disease	4.73e-05	0.000187	CcSEcCtD
Escitalopram—Urticaria—Rivastigmine—Alzheimer's disease	4.72e-05	0.000187	CcSEcCtD
Escitalopram—Abdominal pain—Rivastigmine—Alzheimer's disease	4.7e-05	0.000186	CcSEcCtD
Escitalopram—Body temperature increased—Rivastigmine—Alzheimer's disease	4.7e-05	0.000186	CcSEcCtD
Escitalopram—Diarrhoea—Donepezil—Alzheimer's disease	4.58e-05	0.000181	CcSEcCtD
Escitalopram—Hypersensitivity—Memantine—Alzheimer's disease	4.48e-05	0.000177	CcSEcCtD
Escitalopram—Dizziness—Donepezil—Alzheimer's disease	4.42e-05	0.000175	CcSEcCtD
Escitalopram—Hypersensitivity—Rivastigmine—Alzheimer's disease	4.38e-05	0.000173	CcSEcCtD
Escitalopram—Asthenia—Memantine—Alzheimer's disease	4.36e-05	0.000173	CcSEcCtD
Escitalopram—Pruritus—Memantine—Alzheimer's disease	4.3e-05	0.00017	CcSEcCtD
Escitalopram—Asthenia—Rivastigmine—Alzheimer's disease	4.26e-05	0.000169	CcSEcCtD
Escitalopram—Vomiting—Donepezil—Alzheimer's disease	4.25e-05	0.000168	CcSEcCtD
Escitalopram—Rash—Donepezil—Alzheimer's disease	4.22e-05	0.000167	CcSEcCtD
Escitalopram—Dermatitis—Donepezil—Alzheimer's disease	4.21e-05	0.000167	CcSEcCtD
Escitalopram—Pruritus—Rivastigmine—Alzheimer's disease	4.2e-05	0.000167	CcSEcCtD
Escitalopram—Headache—Donepezil—Alzheimer's disease	4.19e-05	0.000166	CcSEcCtD
Escitalopram—Diarrhoea—Memantine—Alzheimer's disease	4.16e-05	0.000165	CcSEcCtD
Escitalopram—Diarrhoea—Rivastigmine—Alzheimer's disease	4.07e-05	0.000161	CcSEcCtD
Escitalopram—Dizziness—Memantine—Alzheimer's disease	4.02e-05	0.000159	CcSEcCtD
Escitalopram—Nausea—Donepezil—Alzheimer's disease	3.97e-05	0.000157	CcSEcCtD
Escitalopram—Dizziness—Rivastigmine—Alzheimer's disease	3.93e-05	0.000156	CcSEcCtD
Escitalopram—Vomiting—Memantine—Alzheimer's disease	3.86e-05	0.000153	CcSEcCtD
Escitalopram—Rash—Memantine—Alzheimer's disease	3.83e-05	0.000152	CcSEcCtD
Escitalopram—Dermatitis—Memantine—Alzheimer's disease	3.83e-05	0.000152	CcSEcCtD
Escitalopram—Headache—Memantine—Alzheimer's disease	3.81e-05	0.000151	CcSEcCtD
Escitalopram—Vomiting—Rivastigmine—Alzheimer's disease	3.78e-05	0.00015	CcSEcCtD
Escitalopram—Rash—Rivastigmine—Alzheimer's disease	3.75e-05	0.000148	CcSEcCtD
Escitalopram—Dermatitis—Rivastigmine—Alzheimer's disease	3.74e-05	0.000148	CcSEcCtD
Escitalopram—Headache—Rivastigmine—Alzheimer's disease	3.72e-05	0.000147	CcSEcCtD
Escitalopram—Nausea—Memantine—Alzheimer's disease	3.61e-05	0.000143	CcSEcCtD
Escitalopram—Nausea—Rivastigmine—Alzheimer's disease	3.53e-05	0.00014	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	8.77e-06	0.000185	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	8.77e-06	0.000185	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PTK2B—Alzheimer's disease	8.77e-06	0.000185	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	8.76e-06	0.000185	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CHAT—Alzheimer's disease	8.74e-06	0.000185	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPI1—Alzheimer's disease	8.74e-06	0.000185	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	8.74e-06	0.000184	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	8.73e-06	0.000184	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.67e-06	0.000183	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	8.62e-06	0.000182	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	8.6e-06	0.000182	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.59e-06	0.000181	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SST—Alzheimer's disease	8.53e-06	0.00018	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GAB2—Alzheimer's disease	8.53e-06	0.00018	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NTRK2—Alzheimer's disease	8.53e-06	0.00018	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	8.5e-06	0.000179	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	8.5e-06	0.000179	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SST—Alzheimer's disease	8.5e-06	0.000179	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CALM1—Alzheimer's disease	8.49e-06	0.000179	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—A2M—Alzheimer's disease	8.47e-06	0.000179	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	8.47e-06	0.000179	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GSK3A—Alzheimer's disease	8.45e-06	0.000178	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NGFR—Alzheimer's disease	8.44e-06	0.000178	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	8.43e-06	0.000178	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CREB1—Alzheimer's disease	8.39e-06	0.000177	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MAOB—Alzheimer's disease	8.38e-06	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	8.37e-06	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	8.37e-06	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	8.37e-06	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	8.33e-06	0.000176	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APP—Alzheimer's disease	8.31e-06	0.000175	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	8.3e-06	0.000175	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APP—Alzheimer's disease	8.28e-06	0.000175	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADAM10—Alzheimer's disease	8.25e-06	0.000174	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCL2—Alzheimer's disease	8.21e-06	0.000173	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	8.16e-06	0.000172	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	8.07e-06	0.00017	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—F2—Alzheimer's disease	7.98e-06	0.000168	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	7.96e-06	0.000168	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PLCB1—Alzheimer's disease	7.84e-06	0.000166	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	7.83e-06	0.000165	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	7.82e-06	0.000165	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—S100B—Alzheimer's disease	7.8e-06	0.000165	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—A2M—Alzheimer's disease	7.79e-06	0.000164	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	7.69e-06	0.000162	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.55e-06	0.000159	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF2—Alzheimer's disease	7.43e-06	0.000157	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ACHE—Alzheimer's disease	7.37e-06	0.000156	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NGFR—Alzheimer's disease	7.32e-06	0.000154	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	7.29e-06	0.000154	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	7.28e-06	0.000154	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CREB1—Alzheimer's disease	7.27e-06	0.000153	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	7.25e-06	0.000153	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	7.18e-06	0.000152	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1R—Alzheimer's disease	7.18e-06	0.000152	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADAM10—Alzheimer's disease	7.15e-06	0.000151	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	7.13e-06	0.000151	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	7.12e-06	0.00015	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL2—Alzheimer's disease	7.11e-06	0.00015	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	7.09e-06	0.00015	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	7.01e-06	0.000148	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	6.98e-06	0.000147	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ENO1—Alzheimer's disease	6.91e-06	0.000146	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	6.91e-06	0.000146	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LPL—Alzheimer's disease	6.88e-06	0.000145	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MEF2C—Alzheimer's disease	6.82e-06	0.000144	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ACHE—Alzheimer's disease	6.78e-06	0.000143	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	6.77e-06	0.000143	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—S100B—Alzheimer's disease	6.76e-06	0.000143	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	6.74e-06	0.000142	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	6.7e-06	0.000141	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	6.69e-06	0.000141	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	6.63e-06	0.00014	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	6.52e-06	0.000138	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	6.43e-06	0.000136	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—BCHE—Alzheimer's disease	6.42e-06	0.000136	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	6.41e-06	0.000135	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.35e-06	0.000134	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.35e-06	0.000134	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	6.34e-06	0.000134	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	6.31e-06	0.000133	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	6.22e-06	0.000131	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	6.21e-06	0.000131	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	6.2e-06	0.000131	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	6.1e-06	0.000129	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	6.06e-06	0.000128	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LPL—Alzheimer's disease	5.96e-06	0.000126	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	5.95e-06	0.000125	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.94e-06	0.000125	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	5.91e-06	0.000125	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.9e-06	0.000125	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	5.89e-06	0.000124	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	5.87e-06	0.000124	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	5.85e-06	0.000124	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	5.8e-06	0.000122	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	5.8e-06	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	5.79e-06	0.000122	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	5.78e-06	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	5.77e-06	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	5.77e-06	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	5.72e-06	0.000121	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.72e-06	0.000121	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.72e-06	0.000121	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	5.69e-06	0.00012	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NGF—Alzheimer's disease	5.65e-06	0.000119	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	5.63e-06	0.000119	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.57e-06	0.000118	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	5.54e-06	0.000117	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	5.51e-06	0.000116	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	5.5e-06	0.000116	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.48e-06	0.000116	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	5.48e-06	0.000116	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—F2—Alzheimer's disease	5.44e-06	0.000115	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.4e-06	0.000114	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	5.39e-06	0.000114	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	5.38e-06	0.000114	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	5.36e-06	0.000113	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	5.32e-06	0.000112	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	5.28e-06	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.27e-06	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.09e-06	0.000108	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	5.06e-06	0.000107	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	5.04e-06	0.000106	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	5.02e-06	0.000106	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	5e-06	0.000106	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—Alzheimer's disease	5e-06	0.000106	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—Alzheimer's disease	5e-06	0.000106	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	5e-06	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	4.98e-06	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	4.98e-06	0.000105	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.96e-06	0.000105	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.95e-06	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	4.94e-06	0.000104	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.93e-06	0.000104	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	4.92e-06	0.000104	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	4.91e-06	0.000104	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	4.91e-06	0.000104	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	4.86e-06	0.000103	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.85e-06	0.000102	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.77e-06	0.000101	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	4.77e-06	0.000101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	4.76e-06	0.0001	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.71e-06	9.95e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—F2—Alzheimer's disease	4.7e-06	9.92e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	4.68e-06	9.89e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.65e-06	9.83e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.63e-06	9.78e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	4.63e-06	9.77e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.61e-06	9.74e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPL—Alzheimer's disease	4.61e-06	9.73e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.6e-06	9.71e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.53e-06	9.56e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.43e-06	9.35e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.38e-06	9.25e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	4.33e-06	9.14e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	4.32e-06	9.12e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	4.32e-06	9.11e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	4.29e-06	9.07e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	4.28e-06	9.04e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—INS—Alzheimer's disease	4.27e-06	9.02e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—INS—Alzheimer's disease	4.26e-06	8.99e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	4.25e-06	8.97e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.24e-06	8.95e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	4.21e-06	8.9e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	4.2e-06	8.87e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	4.19e-06	8.85e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	4.19e-06	8.84e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.15e-06	8.77e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.15e-06	8.77e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.15e-06	8.76e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	4.13e-06	8.72e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	4.12e-06	8.7e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	4.12e-06	8.69e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.07e-06	8.6e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	4.05e-06	8.56e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.88e-06	8.18e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.86e-06	8.15e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.86e-06	8.15e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.83e-06	8.08e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.82e-06	8.05e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.75e-06	7.91e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	3.73e-06	7.88e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.7e-06	7.82e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	3.68e-06	7.76e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.67e-06	7.75e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.65e-06	7.7e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.64e-06	7.69e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.56e-06	7.52e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.55e-06	7.5e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.53e-06	7.45e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.52e-06	7.43e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	3.37e-06	7.12e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—Alzheimer's disease	3.36e-06	7.1e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	3.36e-06	7.1e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—INS—Alzheimer's disease	3.3e-06	6.96e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.21e-06	6.77e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.2e-06	6.75e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	3.18e-06	6.71e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	3.17e-06	6.69e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	3.16e-06	6.67e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.15e-06	6.65e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	3.15e-06	6.65e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	3.12e-06	6.59e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	3.11e-06	6.57e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	3.1e-06	6.54e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.09e-06	6.53e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.04e-06	6.42e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—INS—Alzheimer's disease	3.03e-06	6.41e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.03e-06	6.39e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.92e-06	6.17e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.91e-06	6.15e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.91e-06	6.15e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.91e-06	6.13e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.89e-06	6.11e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.87e-06	6.05e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.86e-06	6.04e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.86e-06	6.03e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.77e-06	5.85e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.7e-06	5.7e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2.69e-06	5.68e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.66e-06	5.62e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.65e-06	5.59e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.65e-06	5.59e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.49e-06	5.27e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.48e-06	5.23e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.47e-06	5.21e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.43e-06	5.14e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.43e-06	5.13e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.35e-06	4.97e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.33e-06	4.92e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.32e-06	4.9e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.3e-06	4.86e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	2.15e-06	4.55e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TP53—Alzheimer's disease	2.04e-06	4.3e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2.03e-06	4.29e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.02e-06	4.27e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	2e-06	4.22e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.99e-06	4.19e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—INS—Alzheimer's disease	1.98e-06	4.19e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.87e-06	3.94e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.86e-06	3.93e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.83e-06	3.87e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.74e-06	3.67e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.72e-06	3.63e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.72e-06	3.62e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.69e-06	3.57e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.59e-06	3.36e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.33e-06	2.81e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.22e-06	2.58e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8e-07	1.69e-05	CbGpPWpGaD
